Drug marketing largely left alone in House PDUFA hearings

02/7/2012

Although several entities have called for drug marketing restrictions or greater regulation of direct-to-consumer drug ads to be included in the Prescription Drug User Fee Act V (PDUFA V), there was just one mention of drug marketing during four-plus hours of testimony before the House Energy and Commerce Committee’s Subcommittee on Health at a Feb. 1 PDUFA V hearing. However, industry should not be lulled into thinking that these issues will not re-emerge as negotiations continue, according to Coalition for Healthcare Communication Executive Director John Kamp, who said “we’re watching carefully and remain prepared for a challenge.” Read more.

View Full Article in:

http://www.cohealthcom.org/2012/02/02/house-health-subcommittee-pdufa-v-hearing-...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX